These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 12703669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA, Sakhrani DL.
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N, Klein S, Kaube H, Kienbaum P, Peters J, Gastpar M.
    Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633
    [Abstract] [Full Text] [Related]

  • 5. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D, Koutsogiannis Z, Kronborg I.
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contemporary methods in pharmacotherapy in the opiate dependent treatment.
    Radomska M, Bisaga A, Popik P.
    Przegl Lek; 2000 Dec; 57(10):509-18. PubMed ID: 11199877
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL.
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract] [Full Text] [Related]

  • 12. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression.
    Mannelli P, Gottheil E, Peoples JF, Oropeza VC, Van Bockstaele EJ.
    Biol Psychiatry; 2004 Aug 15; 56(4):261-8. PubMed ID: 15312814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical treatment of opioid addiction and dependence.
    Ling W, Rawson RA, Compton M.
    Methods Mol Med; 2003 Aug 15; 84():285-95. PubMed ID: 12703332
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P, Patkar AA, Peindl K, Murray HW, Wu LT, Hubbard R.
    J Clin Psychopharmacol; 2007 Oct 15; 27(5):468-74. PubMed ID: 17873678
    [Abstract] [Full Text] [Related]

  • 16. Challenges to antagonist blockade during sustained-release naltrexone treatment.
    Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Gossop M, Hegstad S, Kristensen Ø, Waal H.
    Addiction; 2010 Sep 15; 105(9):1633-9. PubMed ID: 20707781
    [Abstract] [Full Text] [Related]

  • 17. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM, Burakov AM, Tsoy MV, Egorova VY, Slavina TY, Grinenko AY, Zvartau EE, Woody GE.
    Addiction; 2007 Jul 15; 102(7):1164-5. PubMed ID: 17498182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J, Metzner C, Paetzold W, Borsutzky M, Ohlmeier M, Passie T, Hauser U, Becker H, Wiese B, Emrich H, Schneider U.
    Addict Biol; 2005 Jun 15; 10(2):157-64. PubMed ID: 16191668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.